U.S. market Closed. Opens in 8 hours 10 minutes

KRYS | Krystal Biotech, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue50.70MN/AN/AN/AN/A1.03MN/AN/A
Cost of Revenue3.09M4.05M2.77M1.85M974.00K141.00K23.00K2.00K
Gross Profit47.60M-4.05M-2.77M-1.85M-974.00K886.00K-23.00K-2.00K
Operating Expenses157.33M120.20M68.28M33.00M22.08M11.92M4.77M1.14M
Selling, General & Admin98.40M77.73M40.39M15.06M6.46M4.16M1.56M402.00K
Research & Development46.43M42.46M27.88M17.94M15.62M7.76M3.21M741.00K
Other Operating Expenses12.50M25.00MN/AN/AN/AN/AN/AN/A
Operating Income-109.73M-145.20M-68.28M-33.00M-22.08M-11.92M-4.77M-1.14M
Other Expenses / Income122.62M5.22M-1.29M832.00K2.99M1.03M-3.15M-7.00K
Before Tax Income12.90M-139.97M-69.57M-32.17M-19.09M-10.89M-7.92M-1.15M
Income Tax Expenses1.97M34.05M2.73M1.64M576.14K-20.14KN/AN/A
Net Income10.93M-139.97M-69.57M-32.17M-19.09M-10.89M-7.92M-1.15M
Interest ExpensesN/A5.22M1.49MN/AN/A1.03M3.15M7.00K
Basic Shares Outstanding27.15M25.49M22.20M18.79M15.90M11.20M5.36M4.28M
Diluted Shares Outstanding27.75M25.49M22.20M18.79M15.90M11.20M5.36M4.28M
EBITDA17.90M-145.20M-65.31M-30.32M-18.11M-10.75M-4.63M-1.14M
EBITDA Margin35.31%0.00%0.00%0.00%0.00%-1,046.54%0.00%0.00%
EBIT12.90M-100.71M-65.35M-30.52M-18.51M-9.88M-4.77M-1.14M
EBIT Margin25.44%0.00%0.00%0.00%0.00%-962.23%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙